Trial · NCT01965327
Adverse events21
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 21
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Absominal Pain | Gastrointestinal disorders | Interferon Gamma-1b (ACTIMMUNE) | 2 | 12 | |
| other | Diarrhea | Gastrointestinal disorders | Interferon Gamma-1b (ACTIMMUNE) | 1 | 12 | |
| other | Nausea | Gastrointestinal disorders | Interferon Gamma-1b (ACTIMMUNE) | 7 | 12 | |
| other | Vomiting | Gastrointestinal disorders | Interferon Gamma-1b (ACTIMMUNE) | 4 | 12 | |
| other | Chills | General disorders | Interferon Gamma-1b (ACTIMMUNE) | 1 | 12 | |
| other | Fatigue | General disorders | Interferon Gamma-1b (ACTIMMUNE) | 3 | 12 | |
| other | Influenza like illness | Infections and infestations | Interferon Gamma-1b (ACTIMMUNE) | 6 | 12 | |
| other | Pyrexia | General disorders | Interferon Gamma-1b (ACTIMMUNE) | 2 | 12 | |
| other | Contusion | Skin and subcutaneous tissue disorders | Interferon Gamma-1b (ACTIMMUNE) | 1 | 12 | |
| other | Elevated transaminases | Investigations | Interferon Gamma-1b (ACTIMMUNE) | 1 | 12 | |
| other | Decreased Platelet Count | Blood and lymphatic system disorders | Interferon Gamma-1b (ACTIMMUNE) | 1 | 12 | |
| other | Decreased Appetite | General disorders | Interferon Gamma-1b (ACTIMMUNE) | 1 | 12 | |
| other | Myalgia | General disorders | Interferon Gamma-1b (ACTIMMUNE) | 4 | 12 | |
| other | Headache | General disorders | Interferon Gamma-1b (ACTIMMUNE) | 3 | 12 | |
| other | Epistaxis | Respiratory, thoracic and mediastinal disorders | Interferon Gamma-1b (ACTIMMUNE) | 1 | 12 | |
| other | Sinus Congestion | Respiratory, thoracic and mediastinal disorders | Interferon Gamma-1b (ACTIMMUNE) | 1 | 12 | |
| other | Injection Site Pain | Investigations | Interferon Gamma-1b (ACTIMMUNE) | 3 | 12 | |
| other | Injection Site Bruising | General disorders | Interferon Gamma-1b (ACTIMMUNE) | 4 | 12 | |
| other | Injection Site Dermititis | General disorders | Interferon Gamma-1b (ACTIMMUNE) | 1 | 12 | |
| other | Injection Site Discoloration | General disorders | Interferon Gamma-1b (ACTIMMUNE) | 1 | 12 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01965327/events